Results for “ ”

Entry Author Date Location
Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed 10/07/15 National
My Déjà Vu Moment in Genomics: Why We Need Industry Standards Now 09/29/15 San Diego
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
Our Plan for Reinventing Alzheimer’s Disease R&D at UC San Diego 08/28/15 San Diego
Dr. Frances Kelsey: American Hero, Government Regulator 08/12/15 National
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
“Global Health” Must Mean Global Health 07/09/15 Seattle
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
Out of the Digital Health Fog, More Investments Are Coming in 2015 06/29/15 National
The Decade Of The Brain: 25 Years Later 06/25/15 National
With Fresh Eyes, A Return To Biotech’s City Within A City 06/24/15 Boston
Houston Dares to Challenge the Bicoastal Model of Biotech Growth 06/23/15 Texas
25 Years in Biotech 06/22/15 Boston
Transforming Health Care for Those Who Need it Most 06/22/15 Seattle
Summer Reading List: True Tales That Will Inspire and Educate You 06/01/15 Boston
Four Tough Questions Startup CEOs Need to Ask to Scale 05/19/15 Boston
An Open Standard for APIs Could Lead us to Better Health 05/13/15 National
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Believe It or Not, the Government Is Driving Healthcare Innovation 05/01/15 Seattle
Reflections on the “Build to Buy,” Part 2: The Applicability Problem 04/30/15 National
Healthcare Is Transforming Regardless of What Happens to the ACA 04/15/15 Seattle
A New Day for Digital DNA 04/14/15 Boston
Tax Time Alert: Key Things to Know About Founders Preferred Stock 04/10/15 Boston
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
Peter Thiel Brings Libertarian Standup Routine to Harvard 03/30/15 Boston
Fastest Turtle: Healthcare Investing and the U.S. Economy 03/23/15 Boston
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
For Life Science Industry, Social Media Takes on New Significance 02/19/15 Raleigh Durham
Biotech M&A by Slow Simmer: An Inside Look at the Build to Buy Deal 02/18/15 New York
Why Boston Biotech Should Look to London 02/09/15 Boston
Page 1 of 11 next page »